S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35

GoviEx Uranium Stock Forecast, Price & News

+0.04 (+9.09 %)
(As of 09/27/2021 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume933,940 shs
Average Volume746,111 shs
Market CapitalizationC$226.06 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive GXU News and Ratings via Email

Sign-up to receive the latest news and ratings for GoviEx Uranium and its competitors with MarketBeat's FREE daily newsletter.

About GoviEx Uranium

GoviEx Uranium Inc., a mineral resources company, engages in the acquisition, exploration, and development of uranium projects in Africa. The company's flagship property is the Madaouela project located in north-central Niger. It also owns 100% interest in the Mutanga project that consists of 3 mine permits situated to the south of Lusaka, Zambia; and the Falea project located in Mali. The company was formerly known as Govi High Power Exploration Inc. and changed its name to GoviEx Uranium Inc. in September 2008. GoviEx Uranium Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Industrial Metals & Minerals
Year Founded

Sales & Book Value

Annual Sales
Cash Flow
C$0.02 per share
Book Value
C$0.11 per share





Market Cap
C$226.06 million
Next Earnings Date
Not Optionable


Overall MarketRank

1.80 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

GoviEx Uranium (CVE:GXU) Frequently Asked Questions

Is GoviEx Uranium a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoviEx Uranium in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" GoviEx Uranium stock.
View analyst ratings for GoviEx Uranium
or view top-rated stocks.

What stocks does MarketBeat like better than GoviEx Uranium?

Wall Street analysts have given GoviEx Uranium a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GoviEx Uranium wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has GoviEx Uranium's stock been impacted by COVID-19 (Coronavirus)?

GoviEx Uranium's stock was trading at C$0.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GXU shares have increased by 320.0% and is now trading at C$0.42.
View which stocks have been most impacted by COVID-19

What price target have analysts set for GXU?

1 brokerages have issued 1 year target prices for GoviEx Uranium's shares. Their forecasts range from C$0.60 to C$0.60. On average, they anticipate GoviEx Uranium's stock price to reach C$0.60 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price.
View analysts' price targets for GoviEx Uranium
or view top-rated stocks among Wall Street analysts.

Who are GoviEx Uranium's key executives?

GoviEx Uranium's management team includes the following people:
  • Mr. Govind Y. Friedland, Exec. Chairman (Age 46, Pay $219.56k)
  • Mr. Daniel John Major, CEO & Director (Age 56, Pay $268.61k)
  • Ms. Lei Wang CPA, CPA, CGA, B.S.E, Chief Financial Officer (Age 53, Pay $109.96k)
  • Mr. Matthew Lechtzier, Strategic Advisor (Age 65, Pay $25k)
  • Hon. Robert William Hanson, Strategic Advisor (Age 60, Pay $20k)
  • Mr. Jerome Randabel, Chief Geologist
  • Mr. Christopher Mark Lewis, Head of Uranium Marketing
  • Rodrigo Romo, Corp. Sec.

What other stocks do shareholders of GoviEx Uranium own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoviEx Uranium investors own include Tencent (TCEHY), Tellurian (TELL), (UEC), UEX (UEX), Energy Fuels (UUUU), First Majestic Silver (AG), Align Technology (ALGN), AON (AON), Arvinas (ARVN) and Alibaba Group (BABA).

What is GoviEx Uranium's stock symbol?

GoviEx Uranium trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GXU."

How do I buy shares of GoviEx Uranium?

Shares of GXU and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is GoviEx Uranium's stock price today?

One share of GXU stock can currently be purchased for approximately C$0.42.

How much money does GoviEx Uranium make?

GoviEx Uranium has a market capitalization of C$226.06 million.

What is GoviEx Uranium's official website?

The official website for GoviEx Uranium is www.goviex.com.

How can I contact GoviEx Uranium?

The company can be reached via phone at 604-331-9877.

This page was last updated on 9/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.